Company / Current Assets per Share
Arbutus Biopharma Corp Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.50
FY2025
5-year range
$0.50 / $1.79
FY2021-FY2025
Trend
-33.7%
vs FY2024
Sector context
#204 of 210
Health Care
What the data says
Among 210 Health Care companies, Arbutus Biopharma Corp is in the bottom 3% for current assets per share. Current Assets per Share has declined for 5 consecutive years, from $1.97 in FY2020 to $0.50 in FY2025.
Based on SEC 10-K filings.
0.50 in FY2025 with a 5-year CAGR of -24.1%.
Declined from $0.84 to $0.50 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -21.9%
- 5-Year CAGR
- -24.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $0.50 Sector average $170.65
▼
-99.7% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's current assets per share has declined for 5 consecutive years.
- In FY2025, current assets per share decreased 33.7% year-over-year.
- Ranks #204 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.50 | -33.7% |
| FY2024 | $0.75 | -10.6% |
| FY2023 | $0.84 | -19.6% |
| FY2022 | $1.04 | -41.8% |
| FY2021 | $1.79 | -9.1% |
| FY2020 | $1.97 | +16.6% |
| FY2019 | $1.69 | -28.0% |
| FY2018 | $2.35 | -0.1% |
| FY2017 | $2.35 | -2.8% |
| FY2016 | $2.42 | -28.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026